Medico fledgling Unisense gains funding for fertility treatment project  

2007.05.18
Fledgling medico company Unisense based in Aarhus, Jutland, has gained DKK 11.3 m in funding for its Optimization of Fertility Treatment project
Fledgling medico company Unisense based in Aarhus, Jutland, has gained DKK 11.3 m (USD 2 m) in funding from the Danish National Advanced Technology Foundation for its Optimization of Fertility Treatment project. The total budget is DKK 20 m (USD 3.6 m), and the remaining sum will be paid by Unisense and its collaboration partners: Copenhagen University, the University of Aarhus and the University Hospital of Copenhagen.
 
Between 65% and 95% of embryos that are selected and implanted as part of a fertility treatment die within the first 2-3 days. The aim of the project is to develop a clinical instrument and disposable trays with nano-sensors, which will make it possible to measure the viability of individual embryos. If Unisense successfully develops its instrument, it opens the door to a global market for artificial insemination of around DKK 40 bn (USD 7.2 bn).
 
Unisense was established in 1998 by a team of scientists from the University of Aarhus and Copenhagen University. The company is divided into three business areas: Unisense Science, Unisense Medical and Unisense FertiliTech. The news was reported by Erhvervsbladet (The Business Magazine).
 
Link > Unisense 

Next step

Explore business cases

Please contact me

Name
Company
E-mail
Phone
How can we help you?

IDK
We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×